Topical minocycline formulations: Evaluation and comparison of dermal uptake efficacy

• Main Authors: Diana Lac, Maiko Hermsmeier, Xin Chen, Noymi Yam, Akira Yamamoto, Susan Huang, Tanvee Sawant, Kin F. Chan, Usha Nagavarapu
• Format: Article
• Language: English
• Published: Elsevier 2019-12-01
• Series: International Journal of Pharmaceutics: X
• Online Access: http://www.sciencedirect.com/science/article/pii/S2590156719300234

Acne vulgaris is a clinically distinct skin condition with evidence suggesting that inflammation plays a critical role in the pathogenesis of this disorder. Treatment of severe inflammatory acne often involves the use of oral antibiotics, sometimes in combination with topical products. Oral antibiotics often result in systemic side effects and the risks of antibiotic resistance, but no commercial topical minocycline is currently available. We have developed a unique, stable, hydrophilic topical gel formulation with fully solubilized minocycline (MNC-H). Minocycline delivered in our hydrophilic gel remained more stable in situ, resulting in less degradation product (4-epiminocycline) than a lipophilic formulation (MNC-L). The hydrophilic nature of our formulation enabled 2–3 fold increase in delivery into the skin ex vivo compared to a lipophilic counterpart, mostly seen in the epidermis and pilosebaceous units. The lipophilic formulation also appeared to be more occlusive, resulting in higher sebum production in minipigs, which may exacerbate acne vulgaris. As our results indicate, a 1, 2% minocycline hydrophilic gel may deliver sufficient drug (>15 μg/g) to potentially demonstrate clinical efficacy. These findings suggest that topical hydrophilic minocycline gel may provide a novel tool for topical acne therapy. Keywords: Dermal, Anti-microbial, Anti-inflammatory, Tetracycline class, Transepidermal, Hydrophilicity, Acne, Skin